Literature DB >> 15798052

Fat-containing lesions of the liver: radiologic-pathologic correlation.

Srinivasa R Prasad1, Hanlin Wang, Humberto Rosas, Christine O Menias, Vamsi R Narra, William D Middleton, Jay P Heiken.   

Abstract

Fat-containing tumors of the liver are a heterogeneous group of tumors with characteristic histologic features, variable biologic profiles, and variable imaging findings. Benign liver lesions that contain fat include focal or geographic fatty change (steatosis), pseudolesions due to postoperative packing material (omentum), adenoma, focal nodular hyperplasia, lipoma, angiomyolipoma, cystic teratoma, hepatic adrenal rest tumor, pseudolipoma of the Glisson capsule, and xanthomatous lesions in Langerhans cell histiocytosis. Malignant liver lesions that can contain fat include hepatocellular carcinoma, primary and metastatic liposarcoma, and hepatic metastases. Identification of fat within a liver lesion can be critical in characterization of the lesion. The imaging characteristics of a lesion coupled with the pattern of intratumoral fatty change are helpful in narrowing the differential diagnosis. Although the presence of fat can be demonstrated with computed tomography or ultrasound, magnetic resonance imaging is the most specific imaging technique for demonstration of both microscopic and macroscopic fat. (c) RSNA, 2005.

Entities:  

Mesh:

Year:  2005        PMID: 15798052     DOI: 10.1148/rg.252045083

Source DB:  PubMed          Journal:  Radiographics        ISSN: 0271-5333            Impact factor:   5.333


  62 in total

1.  Focal Fatty liver: more than just a radiographic curiosity?

Authors:  Heather M Patton; Joel E Lavine
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-03

Review 2.  Invisible fat on CT: making it visible by MRI.

Authors:  Emre Ünal; Ali Devrim Karaosmanoğlu; Deniz Akata; Mustafa Nasuh Özmen; Muşturay Karçaaltıncaba
Journal:  Diagn Interv Radiol       Date:  2016 Mar-Apr       Impact factor: 2.630

3.  Focal fat mimicking multiple hepatic metastases on FDG PET/CT imaging.

Authors:  Maurice H Zissen; Andrew Quon
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-06-27       Impact factor: 9.236

4.  Epithelioid angiomyolipoma of the liver: cross-sectional imaging findings of 10 immunohistochemically-verified cases.

Authors:  Peng-Ju Xu; Yan Shan; Fu-Hua Yan; Yuan Ji; Ying Ding; Mei-Lin Zhou
Journal:  World J Gastroenterol       Date:  2009-09-28       Impact factor: 5.742

Review 5.  [Diagnosis and differential diagnosis of benign liver tumors and tumor-like lesions].

Authors:  M Galanski; S Jördens; J Weidemann
Journal:  Chirurg       Date:  2008-08       Impact factor: 0.955

6.  Hepatocyte nuclear factor 1α-inactivated hepatocellular adenomas exhibit high (18)F-fludeoxyglucose uptake associated with glucose-6-phosphate transporter inactivation.

Authors:  Kumi Ozaki; Kenichi Harada; Noboru Terayama; Osamu Matsui; Satoshi Saitoh; Yoshito Tomimaru; Takeshi Fujii; Toshifumi Gabata
Journal:  Br J Radiol       Date:  2016-05-20       Impact factor: 3.039

7.  Coincidence of hepatocelluar carcinoma and hepatic angiomyolipomas in tuberous sclerosis complex: a case report.

Authors:  Bin Yang; Wen-Hui Chen; Pei-Zhi Shi; Jing-Jing Xiang; Ru-Jun Xu; Ji-Hong Liu
Journal:  World J Gastroenterol       Date:  2008-02-07       Impact factor: 5.742

8.  MR findings of steatotic focal nodular hyperplasia and comparison with other fatty tumours.

Authors:  Maxime Ronot; Valérie Paradis; Rafael Duran; Anne Kerbaol; Marie-Pierre Vullierme; Jacques Belghiti; Dominique-Charles Valla; Valérie Vilgrain
Journal:  Eur Radiol       Date:  2012-10-14       Impact factor: 5.315

Review 9.  Distinguishing benign from malignant liver tumours.

Authors:  Jay P Heiken
Journal:  Cancer Imaging       Date:  2007-10-01       Impact factor: 3.909

10.  Case report: Fat-containing liver metastases from retroperitoneal liposarcoma.

Authors:  Mahesh Prakash; Sameer Vyas; Alampady Krishna Prasad Shanbhogue; Mandeep Kang; Pranab Dey; Niranjan Khandelwal
Journal:  Indian J Radiol Imaging       Date:  2008-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.